{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-096176","form_type":"8-K","ticker":"ALNY","cik":"0001178670","company_name":"ALNYLAM PHARMACEUTICALS, INC.","filed_at":"2022-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.951370+00:00","generated_at":"2026-06-26T09:20:19.224467+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Director Steven Paul, M.D. to retire from Alnylam Board effective April 16, 2022","bullets":["Steven Paul resigns from Board effective April 16, 2022; no disagreement with company operations.","Board size reduced from 11 to 10 members upon Dr. Paul's departure.","Colleen F. Reitan joins PC&C Committee; Amy W. Schulman remains Chair.","Dr. Paul served on Alnylam Board since September 2010; praised for decade of service."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-096176","json":"https://secwatch.observer/filing/0001193125-22-096176.json","markdown":"https://secwatch.observer/filing/0001193125-22-096176.md","text":"https://secwatch.observer/filing/0001193125-22-096176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/0001193125-22-096176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/d343633d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:20:19.224467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ff11bd2540","claim":"Steven M. Paul resigned as Director at ALNYLAM PHARMACEUTICALS, INC..","evidence_excerpt":"On March 31, 2022, Steven M. Paul, M.D. informed the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) of his resignation from the Board effective as of April 16, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178670/000119312522096176/0001193125-22-096176-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}